Search Results 101-110 of 17401 for colitis

  1. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo ...

  2. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

    25–30 in San Antonio. Findings to be presented are: Patients with microscopic colitis do not have reduced risk of developing colon polyps. Cross-sectional ...

  3. Rectal bleeding Causes - Mayo Clinic

    Ulcerative colitis — a disease that causes ulcers and swelling called inflammation in the lining of the large intestine. Causes shown here are commonly ...

  4. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  5. Infliximab-abda (intravenous route) - Mayo Clinic

    Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...

  6. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis - Mayo Clinic

    The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...

  7. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · Overview · Participation eligibility.

  9. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...

  10. Infliximab (intravenous route) - Mayo Clinic

    Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...